Portal de Periódicos da CAPES

Human Serum α 2 HS-Glycoprotein Modulates in Vitro Bone Resorption*

1988; Oxford University Press; Volume: 66; Issue: 1 Linguagem: Inglês

10.1210/jcem-66-1-187

1945-7197

G. CRAIG COLCLASURE, WELDON LLOYD, M.S. Lamkin, Wayne A. Gonnerman, Robert F. Troxler, Gwynneth D. Offner, W Bürgi, Karl Schmid, Richard B. Nimberg,

Bone health and treatments

We previously isolated a family of bone-resorbing proteins from human cancer ascites fluid and established that the three purified bone-resorbing proteins were chemically and immunochemically related to each other and to alpha-2HS glycoprotein (alpha 2HS). After this finding we purified the normal human serum counterpart of these ascites proteins and studied its effects on bone resorption. The bone-resorbing properties of normal human serum alpha 2HS were examined in vitro over a wide dose range. This normal human serum glycoprotein had a biphasic effect on 45Ca2+ release from bone. More specifically, this protein stimulated bone resorption at the lower concentrations tested, with a maximum effect [treated over control ratio of 2.5 +/- 0.30 (+/- SE); P less than 0.01] at 40 micrograms/mL. In contrast, at doses above 40 micrograms/mL, a sharp decline in calcium mobilization occurred, with a return to baseline occurring above 80 micrograms/mL. These results suggest that serum alpha 2HS may participate in the regulation of bone metabolism in vivo.